Genitourinary Symptoms With Levonorgestrel Releasing Intrauterine Systems
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01730300
: November 21, 2012
Last Update Posted
: May 15, 2013
Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Information provided by (Responsible Party):
murat ekin, Bakirkoy Dr. Sadi Konuk Research and Training Hospital
The main purpose of the study was to evaluate the efficacy of Levonorgestrel Releasing Intrauterine devices (LNR-IUD) on genitourinary symptoms in patients with abnormal uterine bleeding. The patients were asked urogenital distress inventory (UDI) (which includes; irritative symptoms, stress symptoms, obstructive discomfort) and incontinence impact questionnaire (IIQ) (which includes; physical activity, travel, social/relationships, emotional health)questionnaires in the day of application LNR-IUD and six months later this procedure. Statistical analyse will be performed to evaluate the changes in this time period.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
15 Years to 55 Years (Child, Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
15-55 aged women using levonorgestrel releasing intrauterine device for the treatment of menorrhagia or adenomyosis
women using levonorgestrel releasing intrauterine device for the treatment of menorrhagia or adenomyosis